Healeon Medical, Inc.

What Healeon Medical, Inc. does

Healeon Medical, Inc. develops and commercializes the Healeon® line of point-of-care blood separation devices used to generate autologous platelet-rich plasma (PRP) for office-based medical procedures. The company's product suite targets clinicians in three primary specialty verticals — plastic and reconstructive surgery, minimally invasive procedures, and orthopedics and sports medicine — addressing pain points around inconsistent PRP preparation, suboptimal platelet concentrations, and the need for simple, efficient separation processes in office settings.

The product suite consists of two complementary devices. The Healeon HD PRP™ system uses proprietary blood separation technology with 15-mL and 30-mL platelet concentration tubes to produce both high-density and large-volume PRP concentrations from small peripheral blood samples. The Healeon DUET device is a platelet and plasma separator indicated for the safe and rapid preparation of autologous PRP intended to be mixed with autograft or allograft bone prior to application to bony defects. Manufacturing quality is governed under parent company Bimini Health Tech's ISO 13485 certification and MDSAP certification, providing the regulatory and quality-system foundation required for medical device commercialization.

Healeon generates revenue through hardware sales of its single-use and reusable components to clinicians via direct field sales, with quote-based pricing that is not publicly disclosed. The company is operated and marketed as a product brand under privately held parent Bimini Health Tech — a commercial-stage medical device and biologics company headquartered in Plano, Texas (8400 Belleview Drive, Suite 125) — alongside complementary products including PureGraft®, Essence ADM™, Serene Implants, and Dermapose®. No funding rounds, M&A activity, leadership changes, or partnership announcements are documented in the available source data, and the company has not publicly disclosed revenue, headcount trends, or geographic expansion plans beyond the domestic United States market.

Name

Healeon Medical, Inc.

Legal name

Healeon Medical, Inc.

Website

https://healeonmedical.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Healeon Medical, Inc. develops the Healeon® line of point-of-care platelet-rich plasma (PRP) blood separation devices, including the Healeon HD PRP™ tube system and the Healeon DUET separator, sold directly to plastic surgeons, orthopedic specialists, and sports medicine practitioners under parent Bimini Health Tech.

Ownership category

akta.pro rank

Headquarters

HQ city

Solana Beach

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of PRP blood separation products including Healeon HD PRP tubes and Healeon DUET systems to healthcare providers and medical practices for point-of-care patient treatment.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Healeon Medical, Inc. develops and commercializes medical device systems that use advanced blood separation technologies to generate platelet-rich plasma (PRP) at the patient point of care. Its core product suite — Healeon HD PRP™ and Healeon DUET — enables clinicians in office-based settings to isolate and concentrate platelets, proteins, cell concentrates, and antibodies from small peripheral blood samples for use in plastic and reconstructive surgery, minimally invasive procedures, and orthopedics and sports medicine applications.

Product overview

Healeon Medical, Inc. offers a unified product suite focused on advanced blood separation technologies for platelet-rich plasma (PRP) generation. The core offering consists of Healeon HD PRP™ and Healeon DUET — two complementary products that work together to enable clinicians to isolate and concentrate platelets, proteins, cell concentrates, and antibodies from small blood samples. Healeon HD PRP™ provides high-density and large-volume PRP concentrations using specialized 15-mL and 30-mL platelet concentration tubes for office-based procedures. Healeon DUET serves as a platelet and plasma separator for bone graft handling, enabling PRP preparation at the patient point-of-care for mixing with bone graft materials. The suite is designed to optimize platelet concentrations without compromising safety, positioning the technology as a gold standard for platelet isolation and suspension in clinical applications.

Differentiator

Problem solved

Functional benefit

Brands

• Healeon®: PRP Blood Separation Product Suite using advanced blood separation technologies to improve generation of platelet-rich plasma (PRP) with optimal recovery of platelets, proteins, cell concentrates, and antibodies.
• Healeon® HD PRP™
• Healeon® DUET

Products and services

• Healeon HD PRP™ A blood separation system that generates platelet-rich plasma (PRP) for high-density and large-volume applications in office settings. Features 15-mL and 30-mL platelet concentration tubes and is intended for healthcare providers performing plastic surgery, minimally invasive, orthopedic, and sports medicine procedures.
• Healeon DUET Platelet and plasma separator for bone graft handling, indicated for the safe and rapid preparation of autologous PRP from a small sample of peripheral blood at the patient point of care. The PRP is mixed with autograft and/or allograft bone prior to application to a bony defect for improving handling characteristics.

Quantifiable outcome

• Optimal recovery of platelets, proteins, cell concentrates, and antibodies for medical applications

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators3 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Arthrex: Arthrex is the dominant player in point-of-care autologous biologics with its Angel PRP system used by orthopedic and sports medicine practices — directly competing with Healeon HD PRP in office-based PRP generation for orthopedics and sports medicine indications.
• Emcyte Corporation: Emcyte manufactures point-of-care PRP kits (e.g., PurePRP, Signature kits) used by plastic surgeons, orthopedic surgeons, and sports medicine physicians — a head-to-head competitor in HD PRP tube and bone-graft handling segments.
• RegenLab: RegenLab is a Swiss specialist in regenerative medicine with the RegenKit/RegenPRP line of platelet-separating devices — a direct competitor in autologous PRP preparation across aesthetics and orthopedics.
• Isto Biologics: Isto Biologics sells autologous biologics and bone-graft-handling products used by orthopedic and spine surgeons, directly overlapping with Healeon HD PRP / DUET use cases in bone graft handling and orthobiologics.
• Apex Biologix: Apex Biologix distributes PRP kits and trains clinicians in-office PRP protocols for orthopedics and aesthetics — a closely comparable PRP device and training specialist competing for the same office-based physician customers.

Broad incumbents

• Terumo BCT: Terumo BCT is a global leader in blood component collection, processing, and cell therapy manufacturing systems — overlapping with Healeon's blood-separation technology at a much broader portfolio scale (apheresis, cell therapy, hospital blood banks).
• Zimmer Biomet: Zimmer Biomet is a large orthopedic device company with regenerative medicine offerings (e.g., PRP accessories, biologics adjacencies) — a broad incumbent competing for the same orthopedic and sports medicine PRP customers that Healeon sells into.
• Stryker: Stryker operates in orthopedics and surgical equipment with growing biologics adjacencies; relevant as a broad incumbent competing for hospital and orthopedic accounts alongside specialized PRP players like Healeon.

Emerging players

• Medipost (Cartistem / stem cell biologics): Medipost is a Korean cell-therapy specialist with adjacent autologous biologics products — comparable as a regenerative medicine innovator with overlap in autologous point-of-care treatment concepts.
• Cytomedix (acquired by Nuo Therapeutics / later Aurora Health): Cytomedix and successors have developed autologous point-of-care platelet and growth-factor systems targeting wound care and orthopedics — overlapping technology category with Healeon HD PRP / DUET.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healeon Medical, Inc.